Mrs Deanna D Wilcox, OTRL | |
3 Home Health Cir, Saint Albans, VT 05478-9737 | |
(802) 527-7531 | |
Not Available |
Full Name | Mrs Deanna D Wilcox |
---|---|
Gender | Female |
Speciality | Occupational Therapist - Pediatrics |
Location | 3 Home Health Cir, Saint Albans, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861553000 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0200X | Occupational Therapist - Pediatrics | 072-0000430 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Deanna D Wilcox, OTRL 30 Christine Ct, Milton, VT 05468-4196 Ph: (802) 893-7487 | Mrs Deanna D Wilcox, OTRL 3 Home Health Cir, Saint Albans, VT 05478-9737 Ph: (802) 527-7531 |
News Archive
NYU Langone Medical Center today announced that the Paolo and Marlene Fresco Foundation (Fresco Foundation) has generously given $25 million to establish the international Marlene and Paolo Fresco Institute for Parkinson's & Movement Disorders.
The study involved 2.27 million people who were born in Denmark between 1950 and 1987, and were identified from national registers. Personal and family histories of epilepsy and psychosis were obtained, and individuals were monitored for up to 25 years.
Despite medical advances in colon cancer screening and treatment, people with a lower socioeconomic status remain at a higher risk of dying from colon cancer. A new study in The Milbank Quarterly finds that states and communities that focus on increasing the adoption of innovative health care practices along with providing greater access to public health information can reduce these deaths.
Researchers at the University of Dundee have identified a way of inactivating a naturally occurring human protein, a development which could offer new routes to developing cancer prevention treatments.
AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTabâ„¢ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.
› Verified 9 days ago
Tasia Carlyle, MSOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 596 Sheldon Rd, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Jennifer Ann Mcavey, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-1064 Fax: 802-524-1025 | |
Erin Aimee Medick, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 802-524-1064 Fax: 802-524-1025 | |
Caitlin Marie Rollet, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 596 Sheldon Rd, Saint Albans Healthcare And Rehabilitation Center, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Katherine J Moody, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 110 Fairfax Rd, Saint Albans, VT 05478 Phone: 802-752-1600 | |
Brenda Lee Wardner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 596 Sheldon Rd, Saint Albans, VT 05478 Phone: 802-524-6534 | |
Melissa Dawn Rafferty, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 133 Fairfield St, Saint Albans, VT 05478 Phone: 804-524-1064 Fax: 802-524-1025 |